Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine dose effect on propofol ED50 for painless abortion anesthesia
ChiCTR2300068857Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital of Anhui Medical University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of esketamine and propofol (2 arms), sponsored by First Affiliated Hospital of Anhui Medical University. Primary endpoints: Propofol ED50 and Incidence of respiratory depression. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
esketaminepropofol
Beyond the preview
Go deeper on ChiCTR2300068857.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068857.